Engineering and application of P450 monooxygenases in pharmaceutical and metabolite synthesis.

Cytochrome P450 monoxygenase (P450s or CYPs) allow access to drug metabolites, necessary for approval of new therapeutics in one step, with increased success being demonstrated using bacterial and fungal P450s. Moreover, 12 of the 13 products of the human metabolism of verapamil can be accessed through engineered and chimeric bacterial P450s. These P450s are also used in the synthesis of pharmaceuticals themselves, including the semi-synthetic production of artemisinin in an engineered cell. The integration of new technologies including ultrasound and polyfluorinated hydrocarbon solvents offers an attractive means by the true synthetic potential of ubiquitous P450s can be fully realised.

[1]  R. Fasan.  Tuning P450 Enzymes as Oxidation Catalysts , 2012 .

[2]  Keiko Yamamoto,et al.  The roles of cytochrome P450 enzymes in prostate cancer development and treatment. , 2012, Anticancer research.

[3]  Metabolism of dextrorphan by CYP2D6 in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism. , 2009, Journal of pharmaceutical sciences.

[4]  Gheorghe-Doru Roiban,et al.  Achieving Regio‐ and Enantioselectivity of P450‐Catalyzed Oxidative CH Activation of Small Functionalized Molecules by Structure‐Guided Directed Evolution , 2012, Chembiochem : a European journal of chemical biology.

[5]  F. Arnold,et al.  Thermostabilization of a Cytochrome P450 Peroxygenase , 2003, Chembiochem : a European journal of chemical biology.

[6]  Huimin Zhao,et al.  Inverting the enantioselectivity of P450pyr monooxygenase by directed evolution. , 2010, Chemical communications.

[7]  J. Halpert,et al.  Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation. , 2002, Molecular pharmacology.

[8]  C. M. Ribeiro,et al.  Ultrasound in enzymatic resolution of ethyl 3-hydroxy-3-phenylpropanoate , 2001 .

[9]  V. Urlacher,et al.  Construction of a thermostable cytochrome P450 chimera derived from self-sufficient mesophilic parents , 2007, Applied Microbiology and Biotechnology.

[10]  M. Schittmayer,et al.  A Diversified Library of Bacterial and Fungal Bifunctional Cytochrome P450 Enzymes for Drug Metabolite Synthesis , 2009 .

[11]  G. Gilardi,et al.  Identification of mutant Asp251Gly/Gln307His of cytochrome P450 BM3 for the generation of metabolites of diclofenac, ibuprofen and tolbutamide. , 2012, Chemistry.

[12]  R. Bernhardt,et al.  CYP105A1 mediated 3-hydroxylation of glimepiride and glibenclamide using a recombinant Bacillus megaterium whole-cell catalyst. , 2012, Journal of biotechnology.

[13]  H. Weber,et al.  The concept of docking and protecting groups in biohydroxylation. , 2001, Chemistry.

[14]  N. Turner,et al.  Cytochromes P450 as useful biocatalysts: addressing the limitations. , 2011, Chemical communications.

[15]  M. Mazutti,et al.  Evaluation of activity of a commercial amylase under ultrasound-assisted irradiation. , 2013, Ultrasonics sonochemistry.

[16]  T. Omura.  Structural diversity of cytochrome P450 enzyme system. , 2010, Journal of biochemistry.

[17]  B Crešnar,et al.  Cytochrome P450 enzymes in the fungal kingdom. , 2011, Biochimica et biophysica acta.

[18]  D. Sherman,et al.  Selective oxidation of carbolide C–H bonds by an engineered macrolide P450 mono-oxygenase , 2009, Proceedings of the National Academy of Sciences.

[19]  M. Sheldon,et al.  Water-immiscible dissolved oxygen carriers in combination with Pluronic F 68 in bioreactors , 2010 .

[20]  Sharon Miksys,et al.  Cytochrome P450-mediated drug metabolism in the brain. , 2013, Journal of psychiatry & neuroscience : JPN.

[21]  N. Das,et al.  Microbial Degradation of Petroleum Hydrocarbon Contaminants: An Overview , 2010, Biotechnology research international.

[22]  Timothy S Tracy,et al.  Functional analysis of phenylalanine residues in the active site of cytochrome P450 2C9. , 2008, Biochemistry.

[23]  Kai Knoerzer,et al.  Ultrasound in Enzyme Activation and Inactivation , 2011 .

[24]  Dong-Myung Kim,et al.  Cytochrome P450‐catalyzed O‐dealkylation coupled with photochemical NADPH regeneration , 2013, Biotechnology and bioengineering.

[25]  C. Locuson,et al.  Evaluation of Escherichia coli Membrane Preparations of Canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with Coexpressed Canine Cytochrome P450 Reductase , 2009, Drug Metabolism and Disposition.

[26]  J. Fernandes,et al.  Stereoselective acylations of 1,2-azidoalcohols with vinyl acetate, catalyzed by lipase Amano PS , 2003 .

[27]  A. Fulco.  P450BM-3 and other inducible bacterial P450 cytochromes: biochemistry and regulation. , 1991, Annual review of pharmacology and toxicology.

[28]  K. M. Roberts,et al.  Anilinic N-oxides support cytochrome P450-mediated N-dealkylation through hydrogen-atom transfer. , 2010, Chemistry.

[29]  Gustavo V. Barbosa-Cánovas,et al.  Ultrasound Technologies for Food and Bioprocessing , 2011 .

[30]  Sabine Laschat,et al.  Rational Design of a Minimal and Highly Enriched CYP102A1 Mutant Library with Improved Regio‐, Stereo‐ and Chemoselectivity , 2009, Chembiochem : a European journal of chemical biology.

[31]  W. Miller,et al.  High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductase. , 2011, Endocrinology.

[32]  F. Arnold,et al.  A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. , 2009, Chemistry.

[33]  David Baker,et al.  A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). , 2009, ACS chemical biology.

[34]  H. Griengl,et al.  The use of substrate engineering in biohydroxylation. , 2002, Current opinion in biotechnology.

[35]  Mark S. P. Sansom,et al.  Structure and Dynamics of the Membrane-Bound Cytochrome P450 2C9 , 2011, PLoS Comput. Biol..

[36]  V. Urlacher,et al.  Immobilization of P450 BM-3 monooxygenase on mesoporous molecular sieves with different pore diameters , 2010 .

[37]  G. Grogan.  Cytochromes P450: exploiting diversity and enabling application as biocatalysts. , 2011, Current opinion in chemical biology.

[38]  Craig T. Armstrong,et al.  Constructing manmade enzymes for oxygen activation. , 2013, Dalton transactions.

[39]  T. Imanaka,et al.  Synthesis of optically pure S-sulfoxide by Escherichia coli transformant cells coexpressing the P450 monooxygenase and glucose dehydrogenase genes , 2011, Journal of Industrial Microbiology & Biotechnology.

[40]  M. Elibol,et al.  Effect of perfluorodecalin as an oxygen carrier on actinorhodin production by Streptomyces coelicolor A3(2) , 1995, Applied Microbiology and Biotechnology.

[41]  B. K. Muralidhara,et al.  Engineering mammalian cytochrome P450 2B1 by directed evolution for enhanced catalytic tolerance to temperature and dimethyl sulfoxide. , 2006, Protein engineering, design & selection : PEDS.

[42]  J. Halpert,et al.  Rational engineering of cytochromes P450 2B6 and 2B11 for enhanced stability: Insights into structural importance of residue 334. , 2010, Archives of biochemistry and biophysics.

[43]  Vlada B Urlacher,et al.  Cytochrome P450 monooxygenases: an update on perspectives for synthetic application. , 2012, Trends in biotechnology.

[44]  G. Gilardi,et al.  Optimization of the Bacterial Cytochrome P450 BM3 System for the Production of Human Drug Metabolites , 2012, International journal of molecular sciences.

[45]  P. R. Montellano.  Hydrocarbon hydroxylation by cytochrome P450 enzymes. , 2010 .

[46]  S. Bell,et al.  P450(BM3) (CYP102A1): connecting the dots. , 2012, Chemical Society reviews.

[47]  E. Gillam.  Engineering cytochrome p450 enzymes. , 2008, Chemical research in toxicology.

[48]  Jose Cosme,et al.  Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone , 2004, Science.

[49]  T. Baillie,et al.  Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. , 2008, Chemical research in toxicology.

[50]  G. Lin,et al.  Ultrasound-promoted lipase-catalyzed reactions , 1995 .

[51]  Hua Li,et al.  [Metabolic detoxification of bakuchiol is mediated by cytochrome P450 enzymes in human liver microsomes]. , 2012, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[52]  F. Arnold,et al.  Stereoselective hydroxylation of an achiral cyclopentanecarboxylic acid derivative using engineered P450s BM-3. , 2005, Chemical communications.

[53]  Philip A. Romero,et al.  Exploring protein fitness landscapes by directed evolution , 2009, Nature Reviews Molecular Cell Biology.

[54]  S. Kelly,et al.  The First Virally Encoded Cytochrome P450 , 2009, Journal of Virology.

[55]  F. Arnold,et al.  Laboratory evolution of cytochrome P450 BM‐3 monooxygenase for organic cosolvents , 2004, Biotechnology and bioengineering.

[56]  Matthias Kittelmann,et al.  Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis. , 2010, Biotechnology and Bioengineering.